Synthetic DNA, Genomics, and Biotech Solutions by Twist Bioscience
Twist Bioscience launches new products as stock falls 13.4%
Shares are down 13.4% on the day at $150.17. Twist Bioscience said it has launched new products, including MRD Express and Express Screening Antibodies, featured in its latest newsletter.Twist ...
Viral research panel launch lifts Twist Bioscience stock 6%
Twist Bioscience announced that its Comprehensive Viral Research Panel, capable of identifying thousands of viral species, is now available to order. Shares are up 6% on the day at $115.67.Twist ...
Twist Bioscience stock holds above key $93.53 support as buyers assess next move
Twist Bioscience shared new research from the David Liu lab that leverages AI for improved enzyme design, with the company’s DNA used to support the study. At the same time, Twist Bioscience ...
Twist Bioscience stock edges higher to $101.83 as bullish trend continues and RSI nears overbought
Twist Bioscience shared an example of its Comp Viral panel successfully generating a complete genome from Bundibugyo Ebola virus cases when qPCR-based methods could not. At the same time, Twist ...
Twist Bioscience stock extends rally with upside risk as overbought signals emerge
Twist Bioscience promoted its efforts to combine CAR-T therapy with gene-editing tools for treating disorders beyond cancer. At the same time, Twist Bioscience stock is up 10.3% on the day at ...
Twist Bioscience stock jumps 5.2% after research supports chemotherapy-induced metastasis findings
Twist Bioscience was selected by the @airdlab and its team to provide DNA for research examining how the chemotherapy-induced senescence-associated secretome influences cell detachment and ...
Twist Bioscience delivers cost-effective NGS solutions and edges higher to $91.55
Twist Bioscience says its integrated NGS solutions enable scalable, cost-effective research. The company shared the update in a post on social media.Emily Leproust said researchers achieve deeper, ...
Twist Bioscience stock edges higher with price consolidating above key support levels
Twist Bioscience invites users to get started with its RNAseq offering according to a recent company tweet.Twist Bioscience also provides a link to additional RNA-relevant resources in the same ...
Twist Bioscience stock edges lower to $90.82 after DNA supply chain podcast, Twist Bioscience posts
Twist Bioscience features on the latest episode of ProgressPotent1, with president and COO at the company appearing as a guest. Twist Bioscience states that the episode covers topics ranging from ...
Twist Bioscience stock gains momentum with strong buying as bullish trend accelerates
Twist Bioscience released a newsletter featuring updates on product news, new publications, and research highlights.The company encouraged NGS fans, biotech experts, antibody specialists, ...
Breakout momentum in Twist Bioscience stock after target capture sequencing support announcement
Twist Bioscience announced that target capture-based long-read sequencing was used to unravel missing variants in autosomal recessive disorders.Twist Bioscience thanked the athleta for choosing ...
Twist Bioscience stock drops 3.5% as brand delivers swag event at Caltech, Twist Bioscience
Twist Bioscience visited Caltech to deliver branded merchandise and reconnect with longtime customers and users of Twist DNA. The company described the visit as a great experience.Twist Bioscience ...
Twist Bioscience stock under pressure after new AI protein redesign partnership
Twist Bioscience reported that AI-redesigned starting points and outcomes are enhancing protein evolution.The company thanked David Liu and his team for choosing Twist Bioscience DNA to support ...
Twist Bioscience stock gains 2.32% as CEO weighs WES versus WGS choices
Twist Bioscience said its CEO and co-founder, Emily Leproust, provided input for an article on choosing between whole exome sequencing (WES) and whole genome sequencing (WGS).The company directed ...
Twist Bioscience stock edges higher with price holding above key support despite seller pressure
Twist Bioscience has shared new updates on minimal residual disease, or MRD. The company referenced a recent roundtable held by The Scientist that brought experts together to review the latest MRD ...
Twist Bioscience stock drops 4.13% as new Complex Genes launch rolls out, Twist Bioscience
Twist Bioscience announced that Twist Complex Genes are now available starting at 12¢ per base.The products are shipped within 15 business days. Twist Bioscience invited customers to explore ...
AlphaFold-powered protein redesign aims for safer gene editing while Twist Bioscience stock drops
Twist Bioscience announced that its team uses AlphaFold AI to redesign gene-editing proteins to make them safer.Further information is available at the provided link.[highlights-block]Short-term ...
Twist Bioscience stock drops 2.35% as stable RNA-DNA interface research gains attention, Twist Bioscience reports
Twist Bioscience reported that new research revealed a more stable RNA-DNA interface through structural insights. The company shared the news on social media.Twist Bioscience thanked the authors ...
Twist Bioscience stock climbs 2.58% as landmark gene therapy trial slashes cholesterol, Twist Bioscience states
Twist Bioscience reports a single-dose gene therapy may offer a cure for high cholesterol. Scientists achieved this result in a landmark trial.One shot of the experimental therapy reduced 'bad' ...
Twist Bioscience stock surges 7.38% as Twist Bioscience promotes MRD Express custom target solution
Twist Bioscience announced MRD Express, a custom target enrichment solution for minimal residual disease monitoring.The company describes MRD Express as rapid, scalable, and high-performance. ...
Twist Bioscience stock slides 2.94% as company touts innovation roots, Twist Bioscience
Twist Bioscience marked the Fourth of July by referencing America's tradition of bold ideas and linking it to its work in Wilsonville, Oregon.The company described its mission as 'writing the code ...
